Intravenous Lidocaine Infusion Versus Intravenous Dexmedetomidine Infusion During Sleeve Gastrectomy
Recruiting
N/A
Interventional Study
Bariatric Surgery
Lidocaine
Dexmedetomidine
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 20 – 50
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 40 (estimated)
- Sponsor
- Alexandria University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Although laparoscopic (LAP) bariatric surgery is minimally invasive. Following any laparoscopic procedure, patients typically experience the peak of postoperative pain within the first 24 hours. This intense pain gradually subsides, with significant relief usually occurring by the 2nd or 3rd postoperative day. The initial peak and subsequent decline in pain intensity highlight the importance of ef…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age: 20-50 years, both sexes.
* American Standards Association (ASA) physical status class II to III.
* Body mass index (BMI) 35-50 kg m-².
Exclusion Criteria:
* Cardiac conduction disorders.
* Cardiomyopathy.
* Chronic opioid use.
* Allergy to the studied medications.
* Pre…
Contacts